Expert Review of Anticancer Therapy
(ISSN: 1473-7140)
Show only: Full-text on Medscape
2009 - 9 (6)
- Novel therapeutics for melanoma.
- Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendations.
- Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
- Definition and management of patients with bladder cancer who fail BCG therapy.
- Novel therapeutics for patients with non-muscle-invasive bladder cancer.
- Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma.
- Targeting the Met signaling pathway in renal cancer.
- Current role, techniques and outcomes of percutaneous biopsy of renal tumors.
- Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.
- Laparoscopic nephrectomy for Wilms' tumor.
- Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
- Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
- Trabectedin for the management of soft-tissue sarcoma.
- Rituximab and chemotherapy in diffuse large B-cell lymphoma.
- Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma.
- Should photodynamic diagnosis be standard practice for bladder cancer?
- Value and difficulties of a common European strategy for recurrent Wilms' tumor.
